Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 247

1.

Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer.

Wang SJ, Fuller CD, Kim JS, Sittig DF, Thomas CR Jr, Ravdin PM.

J Clin Oncol. 2008 May 1;26(13):2112-7. doi: 10.1200/JCO.2007.14.7934. Epub 2008 Mar 31.

PMID:
18378567
2.

Prediction model for adjuvant radiation therapy for gallbladder cancer: not ready to be used.

Arroyo GF, Lemoine G.

J Clin Oncol. 2008 Sep 20;26(27):4522-3; author reply 4524-6. doi: 10.1200/JCO.2008.18.2220. No abstract available.

PMID:
18802171
3.

Lymph node evaluation is associated with improved survival after surgery for early stage gallbladder cancer.

Jensen EH, Abraham A, Jarosek S, Habermann EB, Al-Refaie WB, Vickers SA, Virnig BA, Tuttle TM.

Surgery. 2009 Oct;146(4):706-11; discussion 711-3. doi: 10.1016/j.surg.2009.06.056.

PMID:
19789030
4.

Adjuvant therapy for gallbladder carcinoma: the Mayo Clinic Experience.

Gold DG, Miller RC, Haddock MG, Gunderson LL, Quevedo F, Donohue JH, Bhatia S, Nagorney DM.

Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):150-5. doi: 10.1016/j.ijrobp.2008.10.052. Epub 2009 Mar 16.

PMID:
19297105
5.
6.

Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients.

Rees M, Tekkis PP, Welsh FK, O'Rourke T, John TG.

Ann Surg. 2008 Jan;247(1):125-35.

PMID:
18156932
7.
8.

A national propensity-adjusted analysis of adjuvant radiotherapy in the treatment of resected pancreatic adenocarcinoma.

McDade TP, Hill JS, Simons JP, Piperdi B, Ng SC, Zhou Z, Kadish SP, Fitzgerald TJ, Tseng JF.

Cancer. 2010 Jul 1;116(13):3257-66. doi: 10.1002/cncr.25069.

9.

Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.

Da Pozzo LF, Cozzarini C, Briganti A, Suardi N, Salonia A, Bertini R, Gallina A, Bianchi M, Fantini GV, Bolognesi A, Fazio F, Montorsi F, Rigatti P.

Eur Urol. 2009 May;55(5):1003-11. doi: 10.1016/j.eururo.2009.01.046. Epub 2009 Feb 4.

PMID:
19211184
10.

Survival outcomes in resected extrahepatic cholangiocarcinoma: effect of adjuvant radiotherapy in a surveillance, epidemiology, and end results analysis.

Vern-Gross TZ, Shivnani AT, Chen K, Lee CM, Tward JD, MacDonald OK, Crane CH, Talamonti MS, Munoz LL, Small W Jr.

Int J Radiat Oncol Biol Phys. 2011 Sep 1;81(1):189-98. doi: 10.1016/j.ijrobp.2010.05.001. Epub 2010 Oct 23.

PMID:
20971573
11.

Nomograms provide improved accuracy for predicting survival after radical cystectomy.

Shariat SF, Karakiewicz PI, Palapattu GS, Amiel GE, Lotan Y, Rogers CG, Vazina A, Bastian PJ, Gupta A, Sagalowsky AI, Schoenberg M, Lerner SP.

Clin Cancer Res. 2006 Nov 15;12(22):6663-76.

12.

Impact of immediate postoperative death on the estimation of a survival benefit from postoperative radiation therapy for cancer of the gallbladder.

Yu JB, Zelterman D, Decker RH, Knisely JP.

J Clin Oncol. 2008 Sep 20;26(27):4523; author reply 4524-6. doi: 10.1200/JCO.2008.17.4995. No abstract available.

PMID:
18802172
13.

Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer.

Wang SJ, Lemieux A, Kalpathy-Cramer J, Ord CB, Walker GV, Fuller CD, Kim JS, Thomas CR Jr.

J Clin Oncol. 2011 Dec 10;29(35):4627-32. doi: 10.1200/JCO.2010.33.8020. Epub 2011 Nov 7.

14.

Nomogram for survival after primary surgery for bulky stage IIIC ovarian carcinoma.

Chi DS, Palayekar MJ, Sonoda Y, Abu-Rustum NR, Awtrey CS, Huh J, Eisenhauer EL, Barakat RR, Kattan MW.

Gynecol Oncol. 2008 Jan;108(1):191-4. Epub 2007 Oct 24.

PMID:
17950784
15.

Adjuvant therapy for resected gastric cancer--rapid, yet incomplete adoption following results of intergroup 0116 trial.

Coburn NG, Guller U, Baxter NN, Kiss A, Ringash J, Swallow CJ, Law CH.

Int J Radiat Oncol Biol Phys. 2008 Mar 15;70(4):1073-80. Epub 2007 Oct 1.

PMID:
17905529
16.
17.

Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer.

Rouzier R, Pusztai L, Delaloge S, Gonzalez-Angulo AM, Andre F, Hess KR, Buzdar AU, Garbay JR, Spielmann M, Mathieu MC, Symmans WF, Wagner P, Atallah D, Valero V, Berry DA, Hortobagyi GN.

J Clin Oncol. 2005 Nov 20;23(33):8331-9.

PMID:
16293864
18.

Overall survival and cause-specific mortality of patients with stage T1a,bN0M0 breast carcinoma.

Hanrahan EO, Gonzalez-Angulo AM, Giordano SH, Rouzier R, Broglio KR, Hortobagyi GN, Valero V.

J Clin Oncol. 2007 Nov 1;25(31):4952-60.

PMID:
17971593
19.

Stage-specific effect of adjuvant therapy following gastric cancer resection: a population-based analysis of 4,041 patients.

Coburn NG, Govindarajan A, Law CH, Guller U, Kiss A, Ringash J, Swallow CJ, Baxter NN.

Ann Surg Oncol. 2008 Feb;15(2):500-7. Epub 2007 Nov 17.

PMID:
18026800
20.

Neoadjuvant radiation is associated with improved survival in patients with resectable pancreatic cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry.

Stessin AM, Meyer JE, Sherr DL.

Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):1128-33. doi: 10.1016/j.ijrobp.2008.02.065. Epub 2008 Jun 4.

PMID:
18538501

Supplemental Content

Support Center